Category Archives: Blog

Category: Blog. Frontida BioPharm and Oncoceutics Announce Product Development and Commercialization Partnership. AdaptDose™ an Innovative platform.

FB-HRS, LLC Announces US FDA Clearance of IND Application to Initiate Clinical Trial for FBHRS001, a Treatment for Atrial Fibrillation

FB-HRS, LLC Announces US FDA Clearance of IND Application to Initiate Clinical Trial for FBHRS001, a Treatment for Atrial Fibrillation

Atrial Fibrillation impacts a tremendous amount of people around the world and current treatment options are underwhelming due to negative side effects. FB–HRS, LLC has developed a treatment that may reduce those undesired consequences and successfully treat the condition. The next step is a clinical trial, in which the treatment’s viability will be assessed.

AdaptDose™ an Innovative platform

AdaptDose™, The innovation in drug development, that reduces development time by up to 30%

Frontida’s AdaptDose™ technology platform provides a tool that can eliminate the need to reformulate after Phase I and overcomes several technical hurdles in the development and scale up of (1) new molecules, (2) binary and tertiary mixtures of active ingredients, zero and first order drug release matrices, or (3) scalable clinical trial materials used in dose ranging or adaptive dose clinical studies.